New insights into the mechanism of Notch signalling in fibrosis

Open Rheumatology Journal

Volumn 6, Issue 1, 2012, Pages 96-102

  Kavian, Niloufar ^a   Servettaz, Amélie ^b   Weill, Bernard ^a   Batteux, Frédéric ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SERVICE DE DERMATOLOGIE   (France)

Author keywords

Epithelial cells; Epithelial mesenchymal transition; Fibroblasts; Fibrosis; Notch; Reactive oxygen species; Scleroderma; Systemic sclerosis

Indexed keywords

NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR;

CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL FATE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; FIBROGENESIS; FIBROSIS; HEART PROTECTION; HUMAN; KIDNEY FIBROSIS; LUNG FIBROSIS; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SKIN FIBROSIS; SYSTEMIC SCLEROSIS;

EID: 84863946465     PISSN: None     EISSN: 18743129     Source Type: Journal    
DOI: 10.2174/1874312901206010096     Document Type: Review

References (50)

1. Artavanis TS, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999; 284(5415): 770-6.
2. Egan SE, St PB, Leow CC. Notch receptors, partners and regulators: from conserved domains to powerful functions. Curr Top Microbiol Immunol 1998; 228: 273-324.
3. Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev 2006; 7(9): 678-89.
4. Osborne B, Miele L. Notch and the immune system. Immunity 1999; 11(6): 653-63.
5. Fortini ME. Notch signaling: the core pathway and its posttranslational regulation. Dev Cell 2009; 16(5): 633-47.
6. D'Souza B, Miyamoto A, Weinmaster G. The many facets of Notch ligands. Oncogene 2008; 27(38): 5148-67.
7. Brou C, Logeat F, Gupta N, et al. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrinmetalloprotease TACE. Mol Cell 2000; 5(2): 207-16.
8. Okochi M, Steiner H, Fukumori A, et al. Presenilins mediate a dual intramembranous gamma-secretase cleavage of Notch-1. EMBO J 2002; 21(20): 5408-16.
9. Fortini ME. Gamma-secretase-mediated proteolysis in cell-surfacereceptor signalling. Nat Rev 2002; 3(9): 673-84.
10. Gridley T. Notch signaling in vascular development and physiology. Development 2007; 134(15): 2709-18.
11. Ranganathan P, Weaver KL, Capobianco AJ. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 2011; 11(5): 338-51.
12. Lobry C, Oh P, Aifantis I. Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think. J Exp Med 2011; 208(10): 1931-5.
13. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112(12): 1776-84.
14. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110(3): 341-50.
15. Chilosi M, Poletti V, Zamo A, et al. Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol. 2003; 162(5): 1495-502.
16. Timmerman LA, Grego BJ, Raya A, et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev 2004; 18(1): 99-115.
17. Aoyagi IK, Maeno T, Matsui H, et al. Notch induces myofibroblast differentiation of alveolar epithelial cells via transforming growth factor-{beta}-Smad3 pathway. Am J Respir Cell Mol Biol 2011; 45(1): 136-44.
18. Kavian N, Servettaz A, Mongaret C, et al. Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine model. Arthritis Rheum 2010; 62(11): 3477-87.
19. De Bandt M, Meyer O, Ribard P, Kahn M. Rhumatisme fibroblastique. Une nouvelle observation. Rev Rhum Mal Osteoartic 1992; 59: 369.
20. Plantier L, Crestani B, Wert SE, et al. Ectopic respiratory epithelial cell differentiation in bronchiolised distal airspaces in idiopathic pulmonary fibrosis. Thorax 2011; 66(8): 651-7.
21. Bielesz B, Sirin Y, Si H, et al. Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest 2010; 120(11): 4040-54.
22. Russell JL, Goetsch SC, Gaiano NR, Hill JA, Olson EN, Schneider JW. A dynamic notch injury response activates epicardium and contributes to fibrosis repair. Circ Res 2001; 108(1): 51-9.
23. Okuyama R, Tagami H, Aiba S. Notch signaling: its role in epidermal homeostasis and in the pathogenesis of skin diseases. J Dermatol Sci 2008; 49(3): 187-94.
24. LeRoy EC, Medsger TAJ. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28(7): 1573-6.
25. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009; 360: 1989-2003.
26. Dees C, Tomcik M, Zerr P, et al. Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis. Ann Rheum Dis 2011; 70(7): 1304-10.
27. Dees C, Zerr P, Tomcik M, et al. Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis. Arthritis Rheum 2011; 63: 1396-404.
28. Chigurupati S, Arumugam TV, Gen Son T, et al. Involvement of notch signaling in wound healing. PloS One 2007; 2(11): e1167.
29. Allanore Y, Borderie D, Lemarechal H, Ekindjian OG, Kahan A. Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis. Am J Med 2004; 116(9): 595-600.
30. Herrick AL, Matucci Cerinic M. The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clin Exp Rheumatol 2001; 19(1): 4-8.
31. Servettaz A, Guilpain P, Goulvestre C, et al. Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis. Ann Rheum Dis 2007; 66(9): 1202-9.
32. Sambo P, Baroni SS, Luchetti M, et al. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum 2001; 44(11): 2653-64.
33. Ogawa F, Shimizu K, Muroi E, et al. Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis. Rheumatology 2006; 45(7): 815-8.
34. Servettaz A, Goulvestre C, Kavian N, et al. Selective oxidation of DNA topoisomerase 1 induced systemic sclerosis in the mouse. J Immunol 2009; 182(9): 5855-64.
35. Zhang Z, Oliver P, Lancaster JJ, et al. Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme dependent ectodomain shedding induced by phorbol myristate acetate. FASEB J 2001; 15(2): 303-5.
36. Shao MX, Nadel JA. Dual oxidase 1-dependent MUC5AC mucin expression in cultured human airway epithelial cells. Proc Natl Acad Sci USA 2005; 102(3): 767-72.
37. Weijzen S, Rizzo P, Braid M, et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med 2002; 8(9): 979-86.
38. Svegliati S, Cancello R, Sambo P, et al. Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2. J Biol Chem 2005; 280: 36474-82.
39. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001; 345(7): 517-25.
40. Holcomb IN, Kabakoff RC, Chan B, et al. FIZZ1, a novel cysteinerich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 2000; 19(15): 4046-55.
41. Liu T, Dhanasekaran SM, Jin H, et al. FIZZ1 stimulation of myofibroblast differentiation. Am J Pathology 2004; 164(4): 1315-26.
42. Liu T, Hu B, Choi YY, et al. Notch1 signaling in FIZZ1 induction of myofibroblast differentiation. Am J Pathol 2009; 174: 1745-55.
43. Sharma S, Sirin Y, Susztak K. The story of Notch and chronic kidney disease. Curr Opin Nephrol Hypertens 2011; 20(1): 56-61.
44. Niranjan T, Bielesz B, Gruenwald A,-, et al. The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 2008; 14(3): 290-8.
45. Murea M, Park JK, Sharma S, et al. Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function. Kidney Int 2010; 78(5): 514-22.
46. Waters AM, Wu MY, Onay T, et al. Ectopic notch activation in developing podocytes causes glomerulosclerosis. J Am Soc Nephrol 2008; 19(6): 1139-57.
47. High FA, Epstein JA. The multifaceted role of Notch in cardiac development and disease. Nat Rev Genet 2008; 9(1): 49-61.
48. Grego BJ, Luna ZL, del Monte G, et al. Notch signaling is essential for ventricular chamber development. Dev Cell 2007; 12(3): 415-29.
49. Collesi C, Zentilin L, Sinagra G, Giacca M. Notch1 signaling stimulates proliferation of immature cardiomyocytes. J Cell Biol 2008; 183(1): 117-28.
50. Li Y, Hiroi Y, Ngoy S, et al. Notch1 in bone marrow-derived cells mediates cardiac repair after myocardial infarction. Circulation 2011; 123(8): 866-76.